Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
November 24, 1998
Proton-pump inhibitors in acid-related diseases
R R Berardi, L S Welage
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)
|
February 9, 2000
Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases
L S Welage, R R Berardi
The American Journal of Gastroenterology
|
January 5, 2002
Proton pump inhibitors and gastric acid secretion
M M Wolfe, L S Welage, G Sachs
Antimicrobial Agents and Chemotherapy
|
February 1, 1984
Pharmacokinetics of ceftazidime in patients with renal insufficiency
L S Welage, R W Schultz, J J Schentag
DICP : the Annals of Pharmacotherapy
|
October 1, 1989
Safety and acid-suppressant properties of histamine2-receptor antagonists for the prevention of stress-related mucosal damage in critical care patients
J J Schentag, C A Carter, L S Welage
The Annals of Pharmacotherapy
|
April 1, 1994
Risk factors for acute renal insufficiency in patients with suspected or documented bacterial pneumonia
L S Welage, C A Walawander, E G Timm, et al.
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)
|
August 7, 2001
Historical overview of generic medication policy
F J Ascione, D M Kirking, C A Gaither, et al.
Pharmacotherapy
|
August 6, 1998
Determination of fluoxetine and norfluoxetine concentrations in cadaveric allograft skin
B L Neudeck, T E Taddonio, W L Garner, et al.
Pharmacotherapy
|
January 1, 1987
Determinants of antibiotic-associated hypoprothrombinemia
J J Schentag, L S Welage, T H Grasela, et al.
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)
|
August 7, 2001
Economics and structure of the generic pharmaceutical industry
D M Kirking, F J Ascione, C A Gaither, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
November 24, 1998
Proton-pump inhibitors in acid-related diseases
R R Berardi, L S Welage
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)
|
February 9, 2000
Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases
L S Welage, R R Berardi
The American Journal of Gastroenterology
|
January 5, 2002
Proton pump inhibitors and gastric acid secretion
M M Wolfe, L S Welage, G Sachs
Antimicrobial Agents and Chemotherapy
|
February 1, 1984
Pharmacokinetics of ceftazidime in patients with renal insufficiency
L S Welage, R W Schultz, J J Schentag
DICP : the Annals of Pharmacotherapy
|
October 1, 1989
Safety and acid-suppressant properties of histamine2-receptor antagonists for the prevention of stress-related mucosal damage in critical care patients
J J Schentag, C A Carter, L S Welage
The Annals of Pharmacotherapy
|
April 1, 1994
Risk factors for acute renal insufficiency in patients with suspected or documented bacterial pneumonia
L S Welage, C A Walawander, E G Timm, et al.
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)
|
August 7, 2001
Historical overview of generic medication policy
F J Ascione, D M Kirking, C A Gaither, et al.
Pharmacotherapy
|
August 6, 1998
Determination of fluoxetine and norfluoxetine concentrations in cadaveric allograft skin
B L Neudeck, T E Taddonio, W L Garner, et al.
Pharmacotherapy
|
January 1, 1987
Determinants of antibiotic-associated hypoprothrombinemia
J J Schentag, L S Welage, T H Grasela, et al.
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)
|
August 7, 2001
Economics and structure of the generic pharmaceutical industry
D M Kirking, F J Ascione, C A Gaither, et al.
Page
of 4